16-05-2013
In the first six months of financial year 2012/2013 medical technology company Carl Zeiss Meditec increased its revenue by 2.6% compared with the same period of the previous year, to € 443 million. Earnings before interest and tax improved to € 64.1 million (previous year: € 61.1 million); ...
16-05-2013
OPX Biotechnologies, Inc. (OPXBIO) and Evonik Industries AG announced the two companies have entered into an agreement to jointly develop certain bio-based specialty chemicals. The joint-development agreement signed May 3rd 2013 calls for OPXBIO to use its proprietary EDGE™ (Efficiency ...
15-05-2013
During the first six months of fiscal year 2012/13 the business trend in the ZEISS Group was marked by the difficult conditions experienced in some markets. Nevertheless, the Group concluded the first half of the year (ended 31 March) with revenue totaling EUR 1.978 billion (first six months ...
All assets taken over from insolvent company SIRS-Lab GmbH
08-05-2013
Analytik Jena has acquired all of the assets of the insolvent company SIRS-Lab GmbH as part of an asset deal. SIRS-Lab, a company that develops molecular diagnostics methods and testing systems for life-threatening infections like sepsis, had filed for insolvency in December 2012. Analytik ...
07-05-2013
Analytik Jena AG has established a new subsidiary, Analytik Jena Far East (Thailand) Ltd., giving it a presence in the Southeast Asian market. Analytik Jena AG is using this new company to bolster its activities in the Southeast Asian market, increase its regional service for the sales ...
DFG to fund 10 additional projects
30-04-2013
The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) has approved funding for ten additional core facilities to make existing research instrumentation more easily and efficiently accessible to researchers. This decision was made by the DFG's Joint Committee. The projects will ...
24-04-2013
Analytik Jena AG (AJA) expects sales for the current financial year 2012/2013 to exceed EUR 100.0 m for the first time in the Company's history. This was announced today by the manufacturer of analytical instrumentation, life science instruments and optoelectronics in the run-up to its Annual ...
REACH requires tests for skin sensitizing action
12-04-2013
Promega and BASF have jointly developed an alternative method to animal studies that can reliably detect the allergenic potential of substances. Using a newly developed cell line, the reaction of skin cells to allergenic substances can now be demonstrated in the test tube. Allergic skin ...
10-04-2013
Using Fourier transform infrared spectroscopy (FTIR), scientists from Germany were able to differentiate between carcinoma, normal tissue and necrosis, and determine the primary tumour of brain metastasis. Using support vector machines and a training set of known primary tumours, it was ...
04-04-2013
A year ago, the microtechnology, nanotechnology, and advanced materials industry looked out on the year 2012 with quite positive expectations. As it turned out, the unstable economic situation has left its mark on these industries, too. For 2013, at least, the companies expect a slight ...
